activity
20152026
most citedPropensity Score Matching and Subclassification in Observational Studies with Multi-level Treatments

131 citations · 352 across the 94 of their papers we have counts for

collaborators
Showing 2025 · stat.MEShow all

13 papers · 2 filters

stat.ME2025

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation

Yujing Gao, Xiang Zhang, Shu Yang

External controls (ECs) from historical trials or real-world data have gained increasing attention as a way to augment hybrid and single-arm trials, especially when balanced random…

stat.ME2025

Heterogeneity-Aware Federated Causal Inference Leveraging Effect-Measure Transportability

Siqi Cao, Shu Yang

Federated learning of causal estimands offers a powerful strategy to improve estimation efficiency by leveraging data from multiple study sites while preserving privacy. Existing l…

stat.ME2025

Integrating RCTs, RWD, AI/ML and Statistics: Next-Generation Evidence Synthesis

Shu Yang, Margaret Gamalo, Haoda Fu

Randomized controlled trials (RCTs)have been the cornerstone of clinical evidence; however, their cost, duration, and restrictive eligibility criteria limit power and external vali…

stat.ME2025

Multivariate Zero-Inflated Causal Model for Regional Mobility Restriction Effects on Consumer Spending

Taekwon Hong, Wenbin Lu, Shu Yang +1

The COVID-19 pandemic presents challenges to both public health and the economy. Our objective is to examine how household expenditure, a significant component of private demand, r…

stat.ME2025★ 1 cited

Rate doubly robust estimation for weighted average treatment effects

Yiming Wang, Yi Liu, Shu Yang

The weighted average treatment effect (WATE) defines a versatile class of causal estimands for populations characterized by propensity score weights, including the average treatmen…

stat.ME2025

A Spectral Confounder Adjustment for Spatial Regression with Multiple Exposures and Outcomes

Shih-Ni Prim, Yawen Guan, Shu Yang +4

Characterizing social vulnerability is fundamental to disaster response planning. Numerous vulnerability indicators have been developed, but they are typically not validated for th…

stat.ME2025

Doubly Robust Fusion of Many Treatments for Policy Learning

Ke Zhu, Jianing Chu, Ilya Lipkovich +2

Individualized treatment rules/recommendations (ITRs) aim to improve patient outcomes by tailoring treatments to the characteristics of each individual. However, when there are man…

stat.ME2025

Robust Estimation and Inference in Hybrid Controlled Trials for Binary Outcomes: A Case Study on Non-Small Cell Lung Cancer

Jiajun Liu, Ke Zhu, Shu Yang +1

Hybrid controlled trials (HCTs), which augment randomized controlled trials (RCTs) with external controls (ECs), are increasingly receiving attention as a way to address limited po…

stat.ME2025

Integrative Analysis of High-dimensional RCT and RWD Subject to Censoring and Hidden Confounding

Xin Ye, Shu Yang, Xiaofei Wang +1

In this study, we focus on estimating the heterogeneous treatment effect (HTE) for survival outcome. The outcome is subject to censoring and the number of covariates is high-dimens…

stat.ME2025

Doubly robust omnibus sensitivity analysis of externally controlled trials with intercurrent events

Chenyin Gao, Xiang Zhang, Shu Yang

Externally controlled trials are crucial in clinical development when randomized controlled trials are unethical or impractical. These trials consist of a full treatment arm with t…

stat.ME2025

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data

Guangcai Mao, Shu Yang, Xiaofei Wang

The heterogeneous treatment effect plays a crucial role in precision medicine.There is evidence that real-world data, even subject to biases, can be employed as supplementary evide…

stat.ME2025★ 1 cited

Targeted Data Fusion for Region-Specific Survival Effects in the AMP HIV Prevention Trials

Yi Liu, Alexander W. Levis, Ke Zhu +3

The Antibody Mediated Prevention (AMP) trials opened a new scientific frontier by showing that passively administered monoclonal broadly neutralizing antibodies (bnAbs) could preve…

stat.ME2025

COADVISE: Covariate Adjustment with Variable Selection in Randomized Controlled Trials

Yi Liu, Ke Zhu, Larry Han +1

Adjusting for covariates in randomized controlled trials can enhance the credibility and efficiency of treatment effect estimation. However, handling numerous covariates and their…